Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
BMC Pediatr ; 24(1): 224, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38561722

RESUMO

Neonatal compartment syndrome, although rare, has a classic presentation with sentinel skin findings and development of swelling, erythema, and tenderness of the affected extremity. Neonatal compartment syndrome requires prompt surgical intervention to preserve the affected limb and ensure its normal growth and development. Our patient was born at term via vaginal delivery complicated by a compound presentation involving the left upper extremity. No physical exam abnormalities were noted at birth, but she developed signs of neonatal compartment syndrome by 15 h of life. She was surgically treated at 22 h of life and recovered well. At one year of age, she has normal growth and function of the affected extremity. Our case adds to the growing literature associating neonatal compartment syndrome with a compound fetal presentation.


Assuntos
Síndromes Compartimentais , Recém-Nascido , Gravidez , Feminino , Humanos , Síndromes Compartimentais/diagnóstico , Síndromes Compartimentais/etiologia , Síndromes Compartimentais/cirurgia , Parto Obstétrico/efeitos adversos , Apresentação no Trabalho de Parto , Fasciotomia/efeitos adversos
3.
J Pediatr Hematol Oncol ; 46(2): e208-e211, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38117087

RESUMO

Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood (S-EBV-TCL) is a rare disease for which there is no standard of care. S-EBV-TCL is often associated with hemophagocytic lymphohistiocytosis and is generally thought of on the spectrum of EBV-related disease. For the few reported cases of cure in the literature, hematopoietic stem cell transplant has been required because it is the only treatment that has induced complete remission in patients suffering from EBV-associated T-cell or natural killer cell lymphoproliferative diseases, except hemophagocytic lymphohistiocytosis. Here, we present the case of one patient who was successfully cured with a modified regimen of dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin), followed by hematopoietic stem cell transplant using a reduced-intensity conditioning regimen.


Assuntos
Infecções por Vírus Epstein-Barr , Transplante de Células-Tronco Hematopoéticas , Linfo-Histiocitose Hemofagocítica , Linfoma de Células T Periférico , Linfoma de Células T , Humanos , Linfo-Histiocitose Hemofagocítica/patologia , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/terapia , Infecções por Vírus Epstein-Barr/patologia , Herpesvirus Humano 4 , Linfócitos T/patologia , Linfoma de Células T/complicações , Transplante de Células-Tronco Hematopoéticas/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA